| 摘要 |
It is intended to provide a novel chalcone compound having a carbon monoxide inhibitory effect or an aldose reductase inhibitory effect, its derivative or salts thereof; and a drug, a food, a drink or a feed having a therapeutic or preventive effect on a disease with a sensitivity to this compound by taking advantage of the physiological effect of the compound. |
